Agios Pharm Stock Forecast - Price Action Indicator
| AGIO Stock | USD 46.02 2.62 5.39% |
Agios Stock Forecast is based on your current time horizon. Although Agios Pharm's naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Agios Pharm's systematic risk associated with finding meaningful patterns of Agios Pharm fundamentals over time.
Agios |
| Previous Price Action Indicator | Price Action Indicator | Trend |
| 1.82 | (0.46) |
| Check Agios Pharm Volatility | Backtest Agios Pharm | Trend Details |
Agios Pharm Trading Date Momentum
| On November 29 2024 Agios Pharm was traded for 59.39 at the closing time. The top price for the day was 59.86 and the lowest listed price was 58.11 . The trading volume for the day was 237.6 K. The trading history from November 29, 2024 was a factor to the next trading day price boost. The overall trading delta against the next closing price was 1.24% . The overall trading delta against the current closing price is 1.26% . |
Price Action Indicator (or PAIN) was developed by Michael B. Geraty and published in 'Futures' magazine in August 1997.
| Compare Agios Pharm to competition |
Other Forecasting Options for Agios Pharm
For every potential investor in Agios, whether a beginner or expert, Agios Pharm's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Agios Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Agios. Basic forecasting techniques help filter out the noise by identifying Agios Pharm's price trends.Agios Pharm Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Agios Pharm stock to make a market-neutral strategy. Peer analysis of Agios Pharm could also be used in its relative valuation, which is a method of valuing Agios Pharm by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Agios Pharm Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Agios Pharm's price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Agios Pharm's current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Agios Pharm Market Strength Events
Market strength indicators help investors to evaluate how Agios Pharm stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Agios Pharm shares will generate the highest return on investment. By undertsting and applying Agios Pharm stock market strength indicators, traders can identify Agios Pharm entry and exit signals to maximize returns.
| Accumulation Distribution | 317521.0 | |||
| Daily Balance Of Power | (0.38) | |||
| Rate Of Daily Change | 0.95 | |||
| Day Median Price | 47.81 | |||
| Day Typical Price | 47.21 | |||
| Price Action Indicator | (3.10) | |||
| Period Momentum Indicator | (2.62) |
Agios Pharm Risk Indicators
The analysis of Agios Pharm's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Agios Pharm's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting agios stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 2.6 | |||
| Semi Deviation | 4.53 | |||
| Standard Deviation | 4.01 | |||
| Variance | 16.06 | |||
| Downside Variance | 22.89 | |||
| Semi Variance | 20.52 | |||
| Expected Short fall | (2.53) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Pair Trading with Agios Pharm
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Agios Pharm position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Agios Pharm will appreciate offsetting losses from the drop in the long position's value.Moving together with Agios Stock
Moving against Agios Stock
| 0.81 | PFE | Pfizer Inc Fiscal Year End 4th of February 2025 | PairCorr |
| 0.77 | VALN | Valneva SE ADR | PairCorr |
| 0.74 | JNJ | Johnson Johnson Fiscal Year End 28th of January 2025 | PairCorr |
| 0.72 | LLY | Eli Lilly | PairCorr |
| 0.68 | IMAB | I Mab | PairCorr |
The ability to find closely correlated positions to Agios Pharm could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Agios Pharm when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Agios Pharm - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Agios Pharm to buy it.
The correlation of Agios Pharm is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Agios Pharm moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Agios Pharm moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Agios Pharm can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Historical Fundamental Analysis of Agios Pharm to cross-verify your projections. To learn how to invest in Agios Stock, please use our How to Invest in Agios Pharm guide.You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Agios Pharm. If investors know Agios will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Agios Pharm listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share 11.66 | Revenue Per Share 0.582 | Quarterly Revenue Growth 0.212 | Return On Assets (0.18) | Return On Equity 0.5366 |
The market value of Agios Pharm is measured differently than its book value, which is the value of Agios that is recorded on the company's balance sheet. Investors also form their own opinion of Agios Pharm's value that differs from its market value or its book value, called intrinsic value, which is Agios Pharm's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Agios Pharm's market value can be influenced by many factors that don't directly affect Agios Pharm's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Agios Pharm's value and its price as these two are different measures arrived at by different means. Investors typically determine if Agios Pharm is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Agios Pharm's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.